ATI PHARMACOLOGY PROCTOR 2019

ATI PHARMACOLOGY PROCTOR 2019 1.A nurse is assessing a client who is receiving in- travenous therapy. The nurse should identify which of the following findings as a manifestation of fluid volume excess? a. Decreased bowel sounds b. Distended neck veins c. Bilateral muscle weakness d. Thread pulse 2. A nurse is caring for a client who has hyponatremia and is receiving an infusion of a prescribed hyper- tonic solution. Which of the following findings should indicate to the nurse that the treatment is effective? a. Absent Chvostek's sign b. Improved cognition c. Decreased vomiting d. Cardiac arrhythmias absent 3. A nurse is teaching a client who has a new prescrip- tion for a nitroglycerin transdermal patch. Which of the following instructions should the nurse include? a. "Discontinue the patch if you experience a headache." b. "Apply a new patch if you have chest pain." c. "Cover the patch with dry gauze when taking a shower." d. "Remove the patch prior to going to bed." 4. A nurse is reviewing he laboratory results of a client who has a prescription for sodium polystyrene sul- fonate (Kayexalate) every 6 hr. which of the following should the nurse report to the provider? a. Creatinine 0.72 mg/dL b. Sodium 138 mEq/L c. Magnesium 2 mEq/L d. Potassium 5.2 mEq/L b. Distended neck veins b. Improved cogni- tion d. "Remove the patch prior to go- ing to bed." d. Potassium 5.2 mEq/L - Hyper- kalemia (serum potassium level greater than 5.0 mEq/L) increases the client risk for fatal cardiac dys- rhythmias. Kayex- alate is used to decrease the